Changzhou Qianhong Bio-Pharma Co.,Ltd.’s Net Profit Rose 131% in First Quarter of 2022

Changzhou Qianhong Bio-Pharma Co.,Ltd. (常州千红生化制药股份有限公司) (002550.SZ) reported a net profit of 125.8 million yuan in the first quarter of 2022, up 131% year-on-year.

Meanwhile, the company posted 552.2 million yuan in revenue, up 41.2% year-on-year.

At the end of the reporting period, it had 2.7 billion yuan in total assets and 453.8 million yuan in total liabilities, with a liability-to-asset ratio of 16.8%.